Middle East Healthcare Company SJSC

The company's capital structure is characterized by a debt-to-equity ratio of 1.36, indicating a moderate reliance on debt financing. Its liquidity position is reflected in a current ratio of 1.55, suggesting it can cover short-term obligations but with limited buffer. The company's return on equity of 16.12% and return on assets of 5.52% indicate strong profitability relative to equity but moderate efficiency in asset utilization. Profitability metrics show the company generates a gross profit of SAR 1.16 billion and an operating income of SAR 387.3 million, translating to a gross margin of 37.4% and an operating margin of 12.5%. These figures are in line with industry norms for healthcare facilities, where operating margins typically range between 10-15%. The company's net income of SAR 301.9 million reflects a net margin of 9.7%, which is consistent with the sector's average performance. The company's revenue is distributed across three segments: inpatient services, outpatient services, and pharmacy sales. While the exact revenue contribution of each segment is not disclosed, the company's operations span 13 hospitals and numerous clinics, indicating a diversified geographic footprint. The company's presence in Saudi Arabia and the broader MENA region suggests exposure to regional economic and regulatory dynamics. The company's growth trajectory is supported by a revenue of SAR 3.1 billion, with a free cash flow of SAR 52.1 million and a capital expenditure of SAR -457.3 million. These figures suggest the company is investing in its infrastructure while maintaining positive cash flow. Analysts project a mean price target of SAR 66.80, with a median of SAR 70.00, indicating a generally positive outlook. Risk factors include a medium liquidity rating and a negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no near-term pressure from share issuance. However, the company's reliance on long-term debt (SAR 2.54 billion) could pose a refinancing risk if interest rates rise. The company has not disclosed any recent events such as filings or transcripts that would indicate significant operational or strategic changes. Recent events and disclosures do not indicate any material changes in the company's operations or strategic direction. The company's financial and operational performance remains stable, with no significant disruptions reported in the latest available data.